Dear Editors, We read with great interest the national analysis by Beaton et al. evaluating faecal immunochemical testing (FIT) for triage of symptomatic colonoscopy using the UK National Endoscopy Database [1]. The scale of the dataset is impressive and the findings strongly support the value of FIT for prioritising colonoscopy in patients at greatest risk of colorectal cancer. However, three issues deserve emphasis before such risk-stratified models are translated into service-level thresholds.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile